That means companies such as Lilly, Novo Nordisk, Sanofi and AstraZeneca will soon ... management system combines a connected insulin pen with glucose-sensing technologies (e.g., glucose meter ...

Novo Nordisk has made its smart insulin pens available in the UK ... The Danish pharma is trying to stay ahead of arch rivals Eli Lilly and Sanofi in an increasingly competitive insulin market ...

The global insulin delivery pen market is poised for remarkable growth, with its valuation projected to increase from USD ...

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

In 2023, the global disposable pen injectors market is expected to be worth USD 25.5 billion. The market is expected to reach USD 54.4 billion by 2033, expanding at a 7.9% CAGR throughout the forecast ...